Sort by
Items per page

Send to

Choose Destination

Search results

Items: 11


Different stages of primary Sjogren's syndrome involving lymphotoxin and type 1 IFN.

Shen L, Suresh L, Malyavantham K, Kowal P, Xuan J, Lindemann MJ, Ambrus JL Jr.

J Immunol. 2013 Jul 15;191(2):608-13. doi: 10.4049/jimmunol.1203440. Epub 2013 Jun 14.


Celiac G+ antibody assay for the detection of autoantibodies in celiac disease.

Bansal AK, Lindemann MJ, Ramsperger V, Kumar V.

Ann N Y Acad Sci. 2009 Sep;1173:36-40. doi: 10.1111/j.1749-6632.2009.04848.x.


Th17 cells and IL-17 receptor signaling are essential for mucosal host defense against oral candidiasis.

Conti HR, Shen F, Nayyar N, Stocum E, Sun JN, Lindemann MJ, Ho AW, Hai JH, Yu JJ, Jung JW, Filler SG, Masso-Welch P, Edgerton M, Gaffen SL.

J Exp Med. 2009 Feb 16;206(2):299-311. doi: 10.1084/jem.20081463. Epub 2009 Feb 9.


Differential regulation of the IL-17 receptor by gammac cytokines: inhibitory signaling by the phosphatidylinositol 3-kinase pathway.

Lindemann MJ, Hu Z, Benczik M, Liu KD, Gaffen SL.

J Biol Chem. 2008 May 16;283(20):14100-8. doi: 10.1074/jbc.M801357200. Epub 2008 Mar 17.


Interleukin-2 enhances the natural killer cell response to Herceptin-coated Her2/neu-positive breast cancer cells.

Carson WE, Parihar R, Lindemann MJ, Personeni N, Dierksheide J, Meropol NJ, Baselga J, Caligiuri MA.

Eur J Immunol. 2001 Oct;31(10):3016-25.


Phenotypic and functional analysis of Fas (CD95) expression in primary central nervous system lymphoma of patients with acquired immunodeficiency syndrome.

Baiocchi RA, Khatri VP, Lindemann MJ, Ross ME, Papoff G, Caprio AJ, Caprio TV, Fenstermaker R, Ruberti G, Bernstein ZP, Caligiuri MA.

Blood. 1997 Sep 1;90(5):1737-46.


A potential role for interleukin-15 in the regulation of human natural killer cell survival.

Carson WE, Fehniger TA, Haldar S, Eckhert K, Lindemann MJ, Lai CF, Croce CM, Baumann H, Caligiuri MA.

J Clin Invest. 1997 Mar 1;99(5):937-43.


Daily subcutaneous injection of low-dose interleukin 2 expands natural killer cells in vivo without significant toxicity.

Meropol NJ, Porter M, Blumenson LE, Lindemann MJ, Perez RP, Vaickus L, Loewen GM, Creaven PJ, Wilkes KA, Giedlin MA, Caligiuri MA.

Clin Cancer Res. 1996 Apr;2(4):669-77.


The functional characterization of interleukin-10 receptor expression on human natural killer cells.

Carson WE, Lindemann MJ, Baiocchi R, Linett M, Tan JC, Chou CC, Narula S, Caligiuri MA.

Blood. 1995 Jun 15;85(12):3577-85.


Interleukin (IL) 15 is a novel cytokine that activates human natural killer cells via components of the IL-2 receptor.

Carson WE, Giri JG, Lindemann MJ, Linett ML, Ahdieh M, Paxton R, Anderson D, Eisenmann J, Grabstein K, Caligiuri MA.

J Exp Med. 1994 Oct 1;180(4):1395-403.

Supplemental Content

Loading ...
Support Center